谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

First Line Atezolizumab + Bevacizumab (atezo/bev) or Durvalumab ± Tremelimumab (durva±treme) in Unresectable Hepatocellular Carcinoma (HCC): A Real World, Multi-Institutional Retrospective Cohort Study.

Ioannis Kournoutas,Paulina S Marell, Anina Peersen, Garima Gupta, Mehmet Akce,Ju Dong Yang, Pin-Jung Chen,Nikolas Naleid,Amit Mahipal,Vaibhav Sahai,Scott Thompson,Zhaohui Jin,Sudhakar Venkatesh,Mitesh J. Borad,Hani M. Babiker,Tanios S. Bekaii-Saab,Robert R. McWilliams,Thorvardur Ragnar Halfdanarson,Fang-Shu Ou,Nguyen H. Tran

Journal of Clinical Oncology（2025）

引用 0|浏览3

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要